Dr. Matthew Scott Kominsky, MD

Dr. Kominsky practices at Northwestern Medicine Palos Hospital in Palos Heights, Illinois, part of Northwestern Memorial HealthCare.

Dr. Kominsky's NPI, 1003159153, was assigned on March 27, 2013. Dr. Kominsky holds Illinois license 036143512.

Dr. Kominsky's primary practice is Northwestern Medicine Palos Hospital, at 12251 South 80th Avenue, Palos Heights, IL 60463 in Cook County. The practice phone is (708) 923-4000.

Dr. Kominsky's primary practice is Northwestern Medicine Palos Hospital in Palos Heights, Illinois, part of Northwestern Memorial HealthCare. Dr. Kominsky is also affiliated with Swedish Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Kominsky to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kominsky practices, 2 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Kominsky's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Kominsky is board certified in anesthesiology by the American Board of Anesthesiology. Dr. Kominsky is licensed in Illinois.

CMS data shows 180 Medicare services from Dr. Kominsky across 10 procedure codes in 2024, for 325 Medicare patients. Medicare paid $21,368 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 325 Medicare patients who saw Dr. Kominsky in 2024. The largest group is 75 to 84, with 141 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kominsky's median patient age at 72, with 53% women.

In 2024, Dr. Kominsky wrote 15 Medicare Part D claims. 80% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $219 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Kominsky for performance year 2024, reported through an alternative payment model (APM). Dr. Kominsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Kominsky from 4 drug and device companies from 2017 to 2019. Travel and lodging make up the largest share, 83% of the total. Vertos Medical, Inc. paid the most, $578.